Methods and compositions comprising at least one α3 4 nAChR antagonist or pharmaceutically acceptable salt thereof

The present invention is directed to methods and formulations for treating, modifying, and/or managing gastrointestinal secretion, and intestinal conditions that cause the same. Methods of using at least one α3 4 nAChR antagonist and formulations comprising at least one α3 4 nAChR antagonist, or pha...

Full description

Saved in:
Bibliographic Details
Main Author DEVANE JOHN
Format Patent
LanguageEnglish
Published 26.05.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention is directed to methods and formulations for treating, modifying, and/or managing gastrointestinal secretion, and intestinal conditions that cause the same. Methods of using at least one α3 4 nAChR antagonist and formulations comprising at least one α3 4 nAChR antagonist, or pharmaceutically acceptable salt thereof, are included.
Bibliography:Application Number: US201213553453